Elevated preoperative peripheral blood monocyte count predicts poor prognosis for hepatocellular carcinoma after curative resection

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Shen, Shun Li ^a   Fu, Shun Jun ^a,b   Huang, Xiong Qing ^a   Chen, Bin ^a   Kuang, Ming ^a   Li, Shao Qiang ^a   Hua, Yun Peng ^a   Liang, Li Jian ^a   Peng, Bao Gang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE   (China)

Author keywords

Hepatic resection; Hepatocellular carcinoma; Monocyte; Prognosis

Indexed keywords

ADULT; ARTICLE; CANCER PROGNOSIS; CELL COUNT; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; OVERALL SURVIVAL; PREOPERATIVE PERIOD; RETROSPECTIVE STUDY; TUMOR VOLUME; AGED; BLOOD; CARCINOMA, HEPATOCELLULAR; LEUKOCYTE COUNT; LIVER NEOPLASMS; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; SURVIVAL; YOUNG ADULT;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LEUKOCYTE COUNT; LIVER NEOPLASMS; MALE; MIDDLE AGED; MONOCYTES; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84908112571     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-744     Document Type: Article

References (35)

1. El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 2012, 142(6):1264-1273. e1, 10.1053/j.gastro.2011.12.061, 3338949, 22537432.
2. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet 2012, 379(9822):1245-1255. 10.1016/S0140-6736(11)61347-0, 22353262.
3. Kobayashi T, Ishiyama K, Ohdan H. Prevention of recurrence after curative treatment for hepatocellular carcinoma. Surg Today 2013, 43(12):1347-1354. 10.1007/s00595-012-0473-5, 23271667.
4. Schlitt HJ, Schnitzbauer AA. Hepatocellular carcinoma: agents and concepts for preventing recurrence after curative treatment. Liver Transpl 2011, 17(Suppl 3):S10-S12.
5. McMillan DC. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 2009, 12(3):223-226. 10.1097/MCO.0b013e32832a7902, 19318937.
6. Gomez D, Farid S, Malik HZ, Young AL, Toogood GJ, Lodge JP, Prasad KR. Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma. World J Surg 2008, 32(8):1757-1762. 10.1007/s00268-008-9552-6, 18340479.
7. Wang GY, Yang Y, Li H, Zhang J, Jiang N, Li MR, Zhu HB, Zhang Q, Chen GH. A scoring model based on neutrophil to lymphocyte ratio predicts recurrence of HBV-associated hepatocellular carcinoma after liver transplantation. PLoS One 2011, 6(9):e25295. 10.1371/journal.pone.0025295, 3180380, 21966488.
8. Kim JM, Kwon CH, Joh JW, Ko JS, Park JB, Lee JH, Kim SJ, Paik SW, Park CK. C-reactive protein may be a prognostic factor in hepatocellular carcinoma with malignant portal vein invasion. World J Surg Oncol 2013, 11:92. 10.1186/1477-7819-11-92, 3644266, 23618082.
9. Sasaki A, Iwashita Y, Shibata K, Matsumoto T, Ohta M, Kitano S. Prognostic value of preoperative peripheral blood monocyte count in patients with hepatocellular carcinoma. Surgery 2006, 139(6):755-764. 10.1016/j.surg.2005.10.009, 16782430.
10. Lee YY, Choi CH, Sung CO, Do IG, Huh S, Song T, Kim MK, Kim HJ, Kim TJ, Lee JW, Kim BG, Bae DS. Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level. Gynecol Oncol 2012, 124(1):92-97. 10.1016/j.ygyno.2011.09.034, 22014631.
11. Sasaki A, Kai S, Endo Y, Iwaki K, Uchida H, Tominaga M, Okunaga R, Shibata K, Ohta M, Kitano S. Prognostic value of preoperative peripheral blood monocyte count in patients with colorectal liver metastasis after liver resection. J Gastrointest Surg 2007, 11(5):596-602. 10.1007/s11605-007-0140-0, 17468918.
12. Schmidt H, Bastholt L, Geertsen P, Christensen IJ, Larsen S, Gehl J, der Maase HV. Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model. Br J Cancer 2005, 93(3):273-278. 10.1038/sj.bjc.6602702, 2361564, 16052222.
13. Sajadieh A, Mouridsen MR, Selmer C, Intzilakis T, Nielsen OW, Haugaard SB. Monocyte number associated with incident cancer and mortality in middle-aged and elderly community-dwelling Danes. Eur J Cancer 2011, 47(13):2015-2022. 10.1016/j.ejca.2011.02.015, 21439818.
14. Halazun KJ, Aldoori A, Malik HZ, Al-Mukhtar A, Prasad KR, Toogood GJ, Lodge JP. Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. Eur J Surg Oncol 2008, 34(1):55-60. 10.1016/j.ejso.2007.02.014, 17448623.
15. Limaye AR, Clark V, Soldevila-Pico C, Morelli G, Suman A, Firpi R, Nelson DR, Cabrera R. Neutrophil-lymphocyte ratio predicts overall and recurrence-free survival after liver transplantation for hepatocellular carcinoma. Hepatol Res 2012, doi:10.1111/hepr.12019.
16. Dan J, Zhang Y, Peng Z, Huang J, Gao H, Xu L, Chen M. Postoperative neutrophil-to-lymphocyte ratio change predicts survival of patients with small hepatocellular carcinoma undergoing radiofrequency ablation. PLoS One 2013, 8(3):e58184. 10.1371/journal.pone.0058184, 3597630, 23516447.
17. Iwase R, Shiba H, Haruki K, Fujiwara Y, Furukawa K, Futagawa Y, Wakiyama S, Misawa T, Yanaga K. Post-operative lymphocyte count may predict the outcome of radical resection for gallbladder carcinoma. Anticancer Res 2013, 33(8):3439-3444.
18. Lee YY, Choi CH, Sung CO, Do IG, Hub SJ, Kim HJ, Kim TJ, Lee JW, Bae DS, Kim BG. Clinical significance of changes in peripheral lymphocyte count after surgery in early cervical cancer. Gynecol Oncol 2012, 127(1):107-113. 10.1016/j.ygyno.2012.05.039, 22710071.
19. Dirkx AE, Oude EMG, Wagstaff J, Griffioen AW. Monocyte/macrophage infiltration in tumors: modulators of angiogenesis. J Leukoc Biol 2006, 80(6):1183-1196. 10.1189/jlb.0905495, 16997855.
20. Heusinkveld M, van der Burg SH. Identification and manipulation of tumor associated macrophages in human cancers. J Transl Med 2011, 9:216. 10.1186/1479-5876-9-216, 3286485, 22176642.
21. Mantovani A, Germano G, Marchesi F, Locatelli M, Biswas SK. Cancer-promoting tumor-associated macrophages: new vistas and open questions. Eur J Immunol 2011, 41(9):2522-2525. 10.1002/eji.201141894, 21952810.
22. Shirabe K, Mano Y, Muto J, Matono R, Motomura T, Toshima T, Takeishi K, Uchiyama H, Yoshizumi T, Taketomi A, Morita M, Tsujitani S, Sakaguchi Y, Maehara Y. Role of tumor-associated macrophages in the progression of hepatocellular carcinoma. Surg Today 2012, 42(1):1-7. 10.1007/s00595-011-0058-8, 22116397.
23. Subimerb C, Pinlaor S, Lulitanond V, Khuntikeo N, Okada S, McGrath MS, Wongkham S. Circulating CD14(+) CD16(+) monocyte levels predict tissue invasive character of cholangiocarcinoma. Clin Exp Immunol 2010, 161(3):471-479. 10.1111/j.1365-2249.2010.04200.x, 2962964, 20636398.
24. Kuang DM, Peng C, Zhao Q, Wu Y, Chen MS, Zheng L. Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells. Hepatology 2010, 51(1):154-164. 10.1002/hep.23291, 19902483.
25. Collins M, Wilhelm M, Conyers R, Herschtal A, Whelan J, Bielack S, Kager L, Kuhne T, Sydes M, Gelderblom H, Ferrari S, Picci P, Smeland S, Eriksson M, Petrilli AS, Bleyer A, Thomas DM. Benefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysis. J Clin Oncol: Official J Am Soc Clin Oncol 2013, 31(18):2303-2312.
26. McElnay P, Lim E. Adjuvant or neoadjuvant chemotherapy for NSCLC. J Thorac Dis 2014, 6(Suppl 2):S224-S227. 4032958, 24868440.
27. Houssami N, Macaskill P, Von MG, Marinovich ML, Mamounas E. Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy. Eur J Cancer (Oxford, Eng: 1990) 2012, 48(18):3342-3354.
28. Peng BG, He Q, Li JP, Zhou F. Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus. Am J Surg 2009, 198(3):313-318. 10.1016/j.amjsurg.2008.09.026, 19285298.
29. Yan Q, Ni J, Zhang GL, Yao X, Yuan WB, Zhou L, Zheng SS. Efficacy of postoperative antiviral combined transcatheter arterial chemoembolization therapy in prevention of hepatitis B-related hepatocellular carcinoma recurrence. Chin Med J (Engl) 2013, 126(5):855-859.
30. Xia Y, Qiu Y, Li J, Shi L, Wang K, Xi T, Shen F, Yan Z, Wu M. Adjuvant therapy with capecitabine postpones recurrence of hepatocellular carcinoma after curative resection: a randomized controlled trial. Ann Surg Oncol 2010, 17(12):3137-3144. 10.1245/s10434-010-1148-3, 20602260.
31. Liang LJ, Hu WJ, Yin XY, Zhou Q, Peng BG, Li DM, Lu MD. Adjuvant intraportal venous chemotherapy for patients with hepatocellular carcinoma and portal vein tumor thrombi following hepatectomy plus portal thrombectomy. World J Surg 2008, 32(4):627-631. 10.1007/s00268-007-9364-0, 18228094.
32. Shen YC, Hsu C, Chen LT, Cheng CC, Hu FC, Cheng AL. Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): a meta-regression approach. J Hepatol 2010, 52(6):889-894. 10.1016/j.jhep.2009.12.041, 20395009.
33. Wong JS, Wong GL, Tsoi KK, Wong VW, Cheung SY, Chong CN, Wong J, Lee KF, Lai PB, Chan HL. Meta-analysis: the efficacy of anti-viral therapy in prevention of recurrence after curative treatment of chronic hepatitis B-related hepatocellular carcinoma. Aliment Pharmacol Ther 2011, 33(10):1104-1112. 10.1111/j.1365-2036.2011.04634.x, 21488914.
34. Hosaka T, Suzuki F, Kobayashi M, Seko Y, Kawamura Y, Sezaki H, Akuta N, Suzuki Y, Saitoh S, Arase Y, Ikeda K, Kobayashi M, Kumada H. Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection. Hepatology (Baltimore, Md) 2013, 58(1):98-107.
35. Li Q, Wang J, Sun Y, Cui YL, Juzi JT, Li HX, Qian BY, Hao XS. Efficacy of postoperative transarterial chemoembolization and portal vein chemotherapy for patients with hepatocellular carcinoma complicated by portal vein tumor thrombosis-a randomized study. World J Surg 2006, 30(11):2004-2011. discussion 2012-2013, 10.1007/s00268-006-0271-6, 17058027.